GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Mesalamine Prolonged Release Tablets IP 1200mg
B. Mesalamine Delayed Release Tablets IP 800mg
C. Mesalamine Delayed Release Tablets IP 400mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Mesalamine Prolonged Release Tablets IP 1200mg
Each film-coated Prolonged release tablet contains:
Mesalamine IP …………………1200mg
Excipients…………………………q.s.
Colour: Iron Oxide Red


B. Mesalamine Delayed Release Tablets IP 800mg
Each film-coated delayed release tablet contains:
Mesalamine IP …………………800mg
Excipients…………………………q.s.
Colour: Ferric Oxide Red

C. Mesalamine Delayed Release Tablets IP 400mg
Each film-coated delayed release tablet contains:
Mesalamine IP …………………400mg
Excipients…………………………q.s.
Colour: Iron Oxide Yellow

THERAPEUTIC INDICATIONS:

Mesalamine is used to treat and prevent flare-ups of mild to moderately active ulcerative colitis (an inflammatory bowel disease). It works inside the bowels to reduce inflammation and other symptoms of the disease. They are indicated for the maintenance of remission of ulcerative colitis in adults. The safety and effectiveness of Asacol for the maintenance of remission of ulcerative colitis in pediatric patients have not been established.

CAUTION & SCHEDULE:

CAUTION: TABLET SHOULD BE SWALLOWED WHOLE & DO NOT CHEWED OR CRUSHED.
SCHEDULE: SCHEDULE H PRESCRIPTION: WARNING: To be sold by retail on the prescription of a Specialist/Gastroenterologist.

STORAGE & DOSAGE:

STORAGE: Store in between 20°C to 25°C.
Excursion are permitted 15°C to 30°C.
Keep in cool & Dry place.
Protect from Light.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Read enclosed leaflet before use.
DOSAGE: AS Directed by The Physician.

Mesalamine Prolonged Release Tablets IP 1200mg Technical Specification:

Product Name:Mesalamine Prolonged Release Tablets IP 1200mg
Brand Name:Meslataj-DR
Strength:1200mg, 800mg, 400mg
Dosage Form:Prolonged Release Film-coated Oral Tablets
Route of Administration:Via Oral Route
Packing:10s, 15s, 50s, 100s
Pack Insert/Leaflet:PIL (Patient Information Leaflet)
Documents:COA, MOA, Stability Studies, GMP
Therapeutic use:Treatment of ulcerative colitis
Indication: Mesalamine is used to treat and prevent flare-ups of mild to moderately active ulcerative colitis (an inflammatory bowel disease). They are indicated for the maintenance of remission of ulcerative colitis in adults.
Storage:Store in between 20°C to 25°C. Excursion are permitted 15°C to 30°C. Keep in cool & Dry place. Protect from Light.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Mesalamine Prolonged Release Tablets IP 1200mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Mesalamine Prolonged Release Tablets IP 1200mg
    Each film-coated Prolonged release tablet contains:
    Mesalamine IP …………………1200mg
    Excipients…………………………q.s.
    Colour: Iron Oxide Red

THERAPEUTIC INDICATIONS:

Mesalamine is used to treat and prevent flare-ups of mild to moderately active ulcerative colitis (an inflammatory bowel disease). It works inside the bowels to reduce inflammation and other symptoms of the disease. They are indicated for the maintenance of remission of ulcerative colitis in adults. The safety and effectiveness of Asacol for the maintenance of remission of ulcerative colitis in pediatric patients have not been established.

CAUTION & SCHEDULE:

CAUTION:  TABLET SHOULD BE SWALLOWED WHOLE & DO NOT CHEWED OR CRUSHED.

SCHEDULE: SCHEDULE H PRESCRIPTION: WARNING: To be sold by retail on the prescription of a Specialist/Gastroenterologist.

STORAGE & DOSAGE:

STORAGE: Store in between 20°C to 25°C. Excursion are permitted 15°C to 30°C. Keep in cool & Dry place.  Protect from Light.

Keep medicine out of reach of children.

Read enclosed leaflet before use.

Dosage: As Directed by the Physician.